CSL Behring

Driven by Our Promise 

It all started with a promise. CSL was founded more than 100 years ago to save lives using the latest technologies. Over the past century, CSL Behring has grown into one of the world's leading biotechnology companies, driven by the promise of saving lives and improving quality of life. We offer the widest range of high-quality plasma-derived and recombinant therapies in the industry. Thanks to our ability to innovate in the development of life-saving medicines, we are known for always putting the patient first. We are CSL Behring and we are committed to our promise.

Focus on rare and serious diseases

Our portfolio of innovative medicines includes a broad spectrum of recombinant and plasma-derived products for the treatment of coagulation disorders, immune deficiencies and chronic inflammatory demyelinating polyneuropathy, as well as products for the treatment of hereditary angioedema and alpha-1-antitrypsin deficiency.

Our values

Commitment to living our values ​​has been the driving force at CSL for many decades. Our values ​​are essential to our success. You help us save lives and protect people's health. They have earned us the reputation of being the trusted and reliable world leader. Our values ​​form the basis of how our employees treat each other, make decisions and solve problems.